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Chronic high fat feeding is correlated with diabetes and kidney disease. However, the impact of short-term high fat diets
(HFD) is not well-understood. Six weeks of HFD result in indices of metabolic syndrome (increased adiposity, hyperglycemia,
hyperinsulinemia, hyperlipidemia, hyperleptinemia, and impaired endothelium-dependent vasodilation) compared to rats fed
on standard chow. The hypothesis was that short-term HFD would induce early signs of renal disease. Young male Sprague-
Dawley rats were fed either HFD (60% fat) or standard chow (5% fat) for six weeks. Morphology was determined by measuring
changes in renal mass and microstructure. Kidney function was measured by analyzing urinary protein, creatinine, and hydrogen
peroxide (H
2
O
2
) concentrations, as well as plasma cystatin C concentrations. Renal damage was measured through assessment
of urinary oxDNA/RNA concentrations as well as renal lipid peroxidation, tumor necrosis factor alpha (TNF𝛼), and interleukin
6 (IL-6). Despite HFD significantly increasing adiposity and renal mass, there was no evidence of early stage kidney disease as
measured by changes in urinary and plasma biomarkers as well as histology. These findings suggest that moderate hyperglycemia
and inflammation produced by short-termHFD are not sufficient to damage kidneys or that the ketogenicHFDmay have protective
effects within the kidneys.
1. Introduction
Diabetes is currently the leading cause of 44% of newly diag-
nosed cases of renal failure [1] as sustained hyperglycemia
damages the filtration membranes of the kidneys resulting
in albuminuria and proteinuria. In fact, proteinuria is often
used as a surrogate marker for renal disease [2–4]. As the
incidence of diabetes continues to increase throughout the
world, rates of albuminuria and diabetic kidney disease
(DKD) are likewise expected to increase [2].
The mechanisms leading to the development of chronic
kidney disease (CKD) in subjects with metabolic syndrome,
however, are not as well-understood [5]. According to
the World Health Organization, the criteria for diagnos-
ing metabolic syndrome indicate that an individual must
have insulin resistance, type 2 diabetes, impaired glucose
tolerance, or impaired fasting glucose along with two addi-
tional criteria: abdominal or overall obesity, dyslipidemia,
hypertension, or microalbuminuria [6].These characteristics
of metabolic syndrome also increase the risk of developing
cardiovascular disease and diabetes, which subsequently
increase the risk of renal dysfunction and failure [6]. Foster
et al. [7] examined data from the Framingham Heart Study
that explored the relationship between renal fat accumu-
lation, hypertension, and CKD. Participants were assessed
for renal fat by computed tomography. Positive associations
were identified between fatty kidney and hypertension and
between fatty kidney and CKD. After adjusting for visceral
adipose tissue, no association was found between fat infiltra-
tion in the kidney and diabetes.These data indicate that there
may be an independent association between hypertension,
renal fat accumulation, and CKD [7].
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Deji et al. [5] showed that feeding 6-week-oldmice a high
fat diet (60% fat) for 12 weeks increased body mass, plasma
glucose, insulin, and triglyceride concentrations and induced
hypertension and kidney disease as evidenced by increased
albuminuria, alterations in renal morphology, and renal lipid
accumulation. Similarly, Altunkaynak et al. [8] demonstrated
that feeding adult female Sprague-Dawley rats a moderate fat
diet (30% fat) for 12 weeks caused the animals to become
overweight and to develop increased kidney masses and
volumes with significant morphological changes indicative
of renal disease. Moreover, renal fat accumulation is evident
with even moderate fat intake in rabbits (10% corn oil +
5% lard for 8–12 weeks) [9]. Stemmer et al. [10] compared
lean chow-fedWistar rats with HFD-fed rats that were either
sensitive or partially resistant to diet-induced obesity after
elevenmonths ofHFD (40%butter fat). A positive correlation
was established between levels of adiposity and the severity
of renal damage. Their results indicate that lipotoxicity is
not a strong contributor to renal dysfunction as they found
that plasma triglyceride and free fatty acid as well as renal
triglyceride levels did not differ significantly between the
treatment and control groups [10].
While long-term feeding protocols are found in the
literature, the effects of shorter-term feeding protocols to
mimic early onset pathological changes within the kidney
following high fat feeding are limited. A variety of rodent
models have been used to investigate the effects of consuming
HFD over the course of eight weeks to 11 months [5, 8, 10, 11],
and although the effects of HFD on kidney morphology have
been studied at four weeks [12], to our knowledge there
are currently no studies that have examined the effects of
shorter-term intake of high fat (as opposed to combined
high carbohydrate, high fat) diets on renal function. For
this reason, the present study was designed to examine the
short-term effects of feeding rats a HFD (60% fat) for six
weeks on renal morphology and biomarkers of function.
Prior studies have shown that young (1.5-month-old) male
Sprague-Dawley rats fed on a HFD (60% kcal from fat) for
as few as six weeks develop indices of metabolic syndrome
and cardiovascular disease: increased visceral adiposity,
hyperglycemia, impaired glucose tolerance, hyperleptinemia,
systemic inflammation (plasma TNF𝛼), lipid peroxidation
(TBARS), and impaired endothelium-dependent vasodila-
tion [13, 14]. Other studies have shown that increased visceral
adiposity, endothelial dysfunction, hypertension, inflamma-
tion, and oxidative stress (characteristics shared by these
animals) increase blood pressure in the kidneys and promote
renal damage, although this has yet to be examined in the 6-
week HFD rat model.Therefore, exploring the effect of short-
term HFD on the kidneys will fill a gap in the literature and
allow for a better understanding of early pathological changes
that occur due to consuming a HFD. It was hypothesized that
six weeks of high fat intake (60% fat) would lead to early
stages of renal disease in 1.5-month-oldmale Sprague-Dawley
rats, as evidenced by morphological and functional changes
in the kidney, compared to control rats on a standard rodent
chow diet (5% fat).
2. Materials and Methods
2.1. Animal Models. Prior studies in our laboratory have
shown that feeding young male (1.5-month-old) Sprague-
Dawley rats (140–160 g bodyweight,HarlanTeklad Industries
(Madison,WI,USA)) aHFD (60%kcal from fat; Cat. number
D12492, Research Diets Inc., New Brunswick, NJ, USA) for
six weeks results in symptoms associated with metabolic
syndrome including increased adiposity, hyperleptinemia,
hyperglycemia, endothelial dysfunction, and hypertension in
comparison to animals fed on standard rodent chow [13, 14].
The current study examined isolated kidneys, plasma, and
urine samples from a subset of animals examined in these
prior IACUC-approved studies from September 2009 to May
2010. Blood samples were obtained via cardiac puncture and
centrifuged at 13,000 rpm at 4∘C for 15 minutes to separate
formed elements from the plasma, which was then stored
at −80∘C until analyses. Urine was collected with a 25-
gauge needle inserted directly into the bladder. The urine
was then centrifuged at 13,000 rpm at 4∘C for 10 minutes
to remove debris and the supernatant was then stored
at −80∘C until analyses. Following a midline laparotomy,
kidneys were removed and stored at −80∘C until analyses
while a separate subset was embedded in Optimal Cutting
Temperature (OCT; Cat. number 4583; Sakura Finetek USA,
Inc., Torrance, CA, USA) compound prior to freezing in
isopentane cooled by liquid nitrogen and storing at −80∘C.
2.2. Morphometrics. Animal morphometrics (body mass,
epididymal fat padmass, waist circumference, and tail length)
and renal tissue masses were measured. Tail length is used
as marker of overall growth in rats [15]. Epididymal fat pad
mass was used to determine variations in adiposity between
HFDand chow-fed rats because the epididymal fat pad can be
easily removed from the animal objectively. Moreover, recent
studies have shown that this fat pad is highly correlated (𝑅2 =
0.94) with total fat volume from the base of the skull to the
distal tibia as measured by in vivomicroCT scans [16].
A subset of frozen kidneys (𝑛 = 4 chow and 𝑛 = 5
HFD rats) embedded in OCT compound were sectioned
using a cryostat (Leica Biosystems CM1950; Buffalo Grove,
IL, USA) and sections (14 𝜇m) were collected onto (+)-
glass microscope slides (Histobond© adhesive slides, VWR
VistaVision, Radnor, PA, USA). Sections were allowed to air-
dry for 10mins and were then fixed with 10% formalin for
an additional 10mins. Following 3-4 washes with tap water,
sectionswere stainedwithMayer’s hematoxylin (Cat. number
6194A16; Hardy Diagnostics, Santa Maria, CA, USA) for
2mins and then rinsed with warm tap water. The slides were
then dipped in acid alcohol (0.5% HCl in 70% ethanol) and
washed in Scotts Tap Water Substitute (Cat. number 26070-
06; Electron Microscopy Sciences, Hatfield, PA, USA) for
5mins followed by a rinse with deionized water. The sections
were then counterstained with Eosin Y (Cat. number IS4054;
Aldon Corporation, Avon, NY, USA) for 3mins followed by
a rinse with tap water and coverslips were mounted onto the
glass microscope slides using SHUR/Mount (Cat. number
LC-W; Triangle Biomedical Sciences, Durham, NC, USA).
Sections were viewed using a light microscope (Olympus
Journal of Nutrition and Metabolism 3
BX50) and images collected with an Olympus DP70 camera
(Melville, NY, USA) to assess morphology.
2.3. Biomarkers of Renal Function. Measuring the excretion
of total proteins in the urine, proteinuria, is a marker of early
renal disease [3, 4]. In fact, multiple studies have found a
stronger association between proteinuria and renal disease
outcomes than any other tested factors [4]. Moreover, clinical
studies on humans have identified proteinuria as among
the first clinical symptoms of kidney damage [17, 18]. Total
urinary protein concentrations were measured on a random
set (𝑛 = 8/group) using the Bradford technique (Cat. number
500-0006; Bio-Rad, Hercules, CA, USA). Urinary creatinine
concentrations were measured on the same set of urine
samples (𝑛 = 8/group) using an available kit (Cat. number
CR01; Oxford Biomedical Research, Rochester Hills, MI) and
values were used to calculate the protein : creatinine ratio.
Interestingly, creatinine clearance is also correlated with risk
of renal failure [19].
Cystatin C produced by nucleated cells is filtered by the
glomerulus and then catabolized by tubular cells in the kidney
[20]. For this reason, plasma concentrations of cystatin C
can be used as a biomarker of glomerular filtration rate [20].
Urinary changes in cystatin C can be used asmarkers of acute
renal injury, although not often used in CKD assessment [21].
Serum creatinine concentrations are likewise often assessed
as a marker of renal function; however, more recent studies
indicate that serum or plasma cystatin C is a stronger, and
more consistent, surrogate indicator of glomerular filtration
rate and renal function [19–27]. Concentrations of cystatin
C in the serum increase as much as 1-2 days prior to
serum creatinine in conditions of acute kidney injuries [21]
as well as in individuals with type 2 diabetes who have
normoalbuminuria [28]. While serum creatinine levels can
be affected by sex, age, diet, muscle mass, and body mass,
cystatin C levels are independent of gender, muscle mass,
and malignancy [21, 27]. Plasma cystatin C was therefore
measured on a subset of samples (𝑛 = 10 per group) using an
available ELISA kit (Cat. number MSCTCO; R&D Systems,
Minneapolis, MN, USA) according to the manufacturer’s
protocol.
Urinary H
2
O
2
, a biomarker of inflammation, oxidative
stress, and renal function, was likewise measured on a subset
of samples (𝑛 = 6 per group) using an available kit (Cat.
number ab102500; Abcam, Cambridge, MA, USA). Crea-
tinine concentrations were measured from the same urine
samples (Cat. number CR01; Oxford Biomedical Research,
Rochester Hills, MI, USA) and the urinary H
2
O
2
: creatinine
ratio was calculated. Urinary and tissue H
2
O
2
levels are often
examined in studies of renal function. The increased renal
perfusion pressure that is associated with hypertension has
been found to elevate excretion of H
2
O
2
[29]. SinceH
2
O
2
can
stimulate proteinuria, it is sometimes used as an indicator of
the initiation of renal pathology [30].
2.4. Inflammatory Markers. Chronic inflammation is often
associated with multiple disease states and has been hypoth-
esized to contribute to both morbidity and mortality in CKD
patients [31]. Studies on animals fed on HFD have found
lipid accumulation in glomeruli and proximal tubules within
the kidneys along with increased expression of inflammatory
markers, particularly tumor necrosis factor alpha (TNF𝛼)
and interleukin-6 (IL-6) [5, 32]. TNF𝛼 production is elevated
with high fat intake and may in part cause insulin resistance
[33] and both inflammatory cytokines can predict risk for
chronic kidney disease [32]. Briefly, a subset of kidneys from
both chow and HFD rats were transferred to a ground glass
homogenizer containing Tris-HCI buffer (10mM Tris (pH
7.6; Cat. number 161-0716; BioRad, Hercules, CA, USA),
1mM EDTA, 1% triton X-100, 0.1% sodium deoxycholate,
0.03% protease inhibitor cocktail (Cat. number P2714; Sigma-
Aldrich, St. Louis, MO, USA), and 1mM phenylmethane-
sulfonyl fluoride (PMSF)). Samples were then centrifuged
at 14,000 rpm for 10 minutes at 4∘C to remove insoluble
debris. Total protein concentrations of the supernatants were
determined using the Bradford Technique (Cat. number 500-
0006; Bio-Rad). Each sample (100 𝜇g total protein)wasmixed
with 6 𝜇L 5x sample buffer (0.6mL 1M Tris-HCl, pH 6.8;
5mL 50% glycerol; 2mL 10% sodium dodecyl sulfate; 1mL
1% bromophenol blue; 0.9mL deionized water and 2% 𝛽-
mercaptoethanol as a reducing agent) and then boiled for 3
minutes.Themixturewas then resolved using 4–15% gradient
Tris-HCl SDS-PAGE gels (Cat. number 456-1083; Bio-Rad)
and transferred to PVDFmembranes (Cat. number 152-0176;
Bio-Rad) for 90 minutes at 200V. Membranes were then
blocked for two hours in Tris buffered saline containing
0.05% Tween 20, 3% BSA fraction V, and 5% nonfat milk
followed by an overnight incubation at 4∘C in primary
antibodies for IL-6 (1 : 250; Cat. number ab6672; Abcam,
Cambridge, MA, USA), TNF𝛼 (1 : 500; Cat. number 11948;
Cell Signaling, Danvers, MA, USA), or the loading control
beta-actin (1 : 2000; Cat. number ab8227; Abcam, Cambridge,
MA,USA). Primary antibodieswere prepared inTris buffered
saline with 0.05% Tween 20 (TTBS). Membranes were then
exposed to anti-rabbit IgG secondary antibody (1 : 1000 for
IL-6 and TNF𝛼 and 1 : 2000 for beta actin; Cat number
7074S; Cell Signaling Technology, Danvers, MA) in TTBS
for one hour at room temperature followed by exposure
to Pierce enhanced chemiluminescence western blotting
substrate (Cat. number 32279; Thermo Scientific, Rockford,
IL, USA) for 1min. Immunoreactive bands were visualized
by exposure to X-ray film (Cat. number 34090; Thermo
Scientific, Rockford, IL, USA) and analyzed using NIH
ImageJ software. Protein expression of IL-6 and TNF𝛼 were
normalized to beta-actin to determine the level of IL-6 (𝑛 = 5
chow and 6 HFD animals) or TNF𝛼 (𝑛 = 8/group) in each
kidney sample.
2.5. Oxidative Stress. Kidneys are especially susceptible to
oxidative stress due to a high concentration of long-chain
polyunsaturated fatty acids, which easily undergo lipid perox-
idation when exposed to reactive oxygen species [34]. Lipid
peroxidation forms malondialdehyde as an end product,
which can be detected via a thiobarbituric acid reactive sub-
stance (TBARS) assay, a marker of oxidative damage that is
often examined. A subset of samples (𝑛 = 5/group) were used
to evaluate renal lipid peroxidation using a commercially
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Table 1: Morphometric measurements.
Measure Chow (𝑛) HFD (𝑛) 𝑝 value
Body mass (g) 349.8 ± 7.98 (9) 376.4 ± 10.3 (8) 0.056
Epididymal fat pad mass (g) 3.49 ± 0.18 (9) 5.60 ± 0.38 (8) <0.001
Waist circumference (cm) 16.59 ± 0.30 (9) 17.96 ± 0.27 (8) 0.004
Tail length (cm) 20.1 ± 0.30 (9) 20.6 ± 0.32 (8) 0.276
Renal mass (g) 1.05 ± 0.04 (9) 1.19 ± 0.04 (8) 0.019
Data expressed as mean ± SEM and analyzed by Student’s 𝑡-tests.
200x 100x
Figure 1: Representative images of hematoxylin and eosin stained renal tissue sections from HFD animals. Hematoxylin and eosin staining
shows no signs of morphological damage.
available TBARS assay kit (Cat. number 0801192; Zep-
toMetrix Corporation, Buffalo, NY, USA).
8-Hydroxy-2󸀠-deoxyguanosine (8-OHdG) is a sensitive
biomarker of oxidative stress in tissue and bodily fluids and
is a major product of damage caused by oxidative stress to
DNA. 8-OHdG is produced by enzymatic cleavage of the
guanine base, the base most prone to oxidation. Plasma
samples (𝑛 = 10 chow; 𝑛 = 11 HFD) were filtered with a
30 kDa ultrafilter (Cat. number UFC503096; EMDMillipore,
Billerica, MA, USA) and 8-hydroxyguanosine, 8-OHdG, and
8-hydroxyguanine were examined as biomarkers of oxidative
DNA and RNA damage using a commercially available kit
(Cat. number 589320; Cayman Chemical, Ann Arbor, MI,
USA), as oxidative stress has been shown to be elevated
during early renal failure.
2.6. Statistical Analyses. Data are expressed as mean ± SEM.
Statistical analyses were computed using SigmaPlot (Systat
Software Inc., Version 13.0; San Jose, CA, USA). Data were
tested for normality and then analyzed using Student’s 𝑡-tests
or the Mann-Whitney 𝑈 tests, as appropriate. 𝑝 values of ≤
0.05 were considered significant.
3. Results
3.1. Morphometrics. Although the HFD rats tended to weigh
more than the chow-fed rats, this difference was not sta-
tistically significant for the animals examined in this study
(Table 1). Rats fed on a HFD demonstrated significantly
increased epididymal fat pad mass compared to chow-fed
animals, establishing that adipositywas increased by theHFD
(Table 1). The waist circumferences of the HFD animals were
significantly increased when compared to chow-fed controls,
indicating that the HFD increased abdominal adiposity
(Table 1). Tail lengths, a marker of overall growth, were not
significantly different (Table 1). The renal masses of the HFD
rats were significantly greater compared to the renal masses
of animals in the chow group (Table 1).
Morphological analyses using hematoxylin and eosin-
stained tissue sections showed no structural differences
between the chow and HFD groups, indicating that although
the mass of the HFD kidneys was increased, damage to the
microstructure of the kidneys was not evident (Figure 1).
3.2. Biomarkers of Renal Function. The urine protein : creat-
inine ratios of the chow and HFD rats did not differ
significantly, indicating that the filtering ability of the HFD
rat kidneys was not damaged (Table 2). There was also
no difference in the urine creatinine concentrations of the
two groups (Table 2). Although HFD plasma cystatin C
concentrations tended to be higher than chow rats, the
difference was not sufficient to merit statistical signifi-
cance (Table 2). Urinary hydrogen peroxide concentrations
were significantly increased in the HFD animals. However,
the H
2
O
2
: creatinine ratios were not significantly different
between the chow and HFD groups (Table 2).
3.3. Inflammatory Markers. Western blot analyses of renal
tissue established no significant difference in the TNF𝛼 pro-
tein expression of the chow and HFD rat kidneys (Figure 2).
Quantification of western blots of IL-6 expression in renal
tissues likewise showed no difference between the kidneys
from chow and HFD rats (Figure 3).
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Table 2: Plasma and urinary markers of renal functionand damage.
Measure Chow (𝑛) HFD (𝑛) 𝑝 value
Urine creatinine (mg/L) 765.0 ± 110.6 (8) 900.3 ± 137.4 (8) 0.456
Urine protein : creatinine ratio (AU) 6.01 ± 2.86 (8) 3.89 ± 1.31 (8) 0.574
Urine H2O2 (pM/𝜇L) 0.023 ± 0.003 (6) 0.048 ± 0.005 (6) 0.002
Urine H2O2 : creatinine ratio (AU) 0.014 ± 0.002 (6) 0.026 ± 0.007 (6) 0.142
Plasma cystatin C (𝜇g/mL) 14.35 ± 0.99 (10) 16.2 ± 1.12 (10) 0.233
Renal TBARS (mM/L) 26.9 ± 2.02 (5) 28.08 ± 0.80 (5) 0.600
Plasma oxDNA/RNA (pg/mL) 887 ± 145 (10) 1003 ± 188 (11) 0.634
Data expressed asmean± SEMand analyzed by Student’s 𝑡-tests with the exception of urine protein : creatinine ratio, whichwas analyzed by theMann-Whitney
𝑈 test.
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Figure 2: Renal tissue TNF𝛼 protein expression in chow and HFD
rats.There was no difference in the TNF𝛼 expression of the two diet
groups (𝑛 = 8/group). Retroperitoneal adipose tissue from a HFD
ratwas used as a positive control (+) and is shown in the first column.
Data were analyzed by Student’s 𝑡-tests and are expressed as means
± SEM. 𝑝 = 0.803.
3.4. Oxidative Stress Markers. Renal TBARS, a measure of
tissue oxidative stress via lipid peroxidation, was not signif-
icantly elevated in the HFD rats (Table 2). Plasma levels of
oxidized DNA and RNA, quantified as plasma levels of mul-
tiple oxidative stress markers including 8-hydroxyguanosine
from RNA, 8-OHdG from DNA, and 8-hydroxyguanine,
were examined.Therewere no significant differences between
the chow and HFD rat groups (Table 2).
4. Discussion
Young (1.5-month-old) male Sprague-Dawley rats fed on
HFD (60% fat) for six weeks developed significant increases
in waist circumference and epididymal fat pad mass along
with a trend towards increased bodymass (Table 1).Therewas
no significant difference in the tail lengths of the animals on
the HFD and chow diets (Table 1), indicating that the animals
were of similar body size.These data also indicate that the rats
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Figure 3: Renal tissue IL-6 protein expression in chow and HFD
rats. There was no difference in the IL-6 expression of the two diet
groups (𝑛 = 5 chow and 6 HFD rats). Retroperitoneal adipose tissue
from a HFD rat was used as a positive control (+) and is shown
in the last column. Data were analyzed by Student’s 𝑡-tests and are
expressed as means ± SEM. 𝑝 = 0.903.
used for the present study developed increased adiposity.The
use of an animal model that mimics the effects of metabolic
syndrome and prediabetes is consistent with prior studies
of HFD intake by both mice and rats [5, 8, 33, 35–39].
Previous studies from our laboratory also demonstrate that
6 weeks of HFD results in hyperglycemia, impaired glucose
tolerance, hypertension, endothelial dysfunction, oxidative
stress (plasma TBARS), and inflammation (plasma TNF𝛼) in
these animals, indicating that the HFD rats are alsomodels of
metabolic syndrome [13, 14].
The renal masses of the HFD rats examined in the present
study were significantly higher than the chow rats (Table 1).
The lack of difference in tail lengths (Table 1) signifies that
the increased mass was not caused by overall growth of
the animals and instead suggests structural damage to the
kidneys. Altunkaynak et al. [8] found similar increases in
body and renal masses of rats fed on HFD (30% fat) for
12 weeks. The increased renal mass may be attributed to
hyperglycemia as proliferation and hypertrophy of mesangial
cells and thickening of the glomerular basement membrane
promote increased renal mass [40] along with vasodilation,
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inflammation, and increased connective tissue [8]. Despite
the increased overall mass of the kidneys, hematoxylin and
eosin staining of the HFD kidneys showed no evidence
of morphological damage (Figure 1). This is in contrast to
long-term studies of HFD that have been shown to cause
morphological renal changes such as glomerular capillary
dilation, enlarged lumens in the tubules and Bowman’s cap-
sule, amassing of extracellular proteins, nephrondegradation,
glomerular membrane thickening, glomerulosclerosis, renal
and tubular interstitial cell necrosis, and shortened tubular
epitheliums [5, 8, 41].
Proteinuria indicates that the filtering ability of the
glomerulus is compromised and allowing proteins, which
normally remain in the blood, to be passed through the fil-
trationmembrane and excreted. In evaluating renal function,
albumin is sometimes specifically examined; however, by
studying total protein excretion, a wider picture of filtration
ability can be ascertained. Proteinuria, specifically, can be
used as a marker of endothelial dysfunction as well as a
surrogate outcome for renal disease progression. Urinary
protein concentrationswere normalized to urinary creatinine
concentrations in order to account for variations in urine
output [42]. Creatinine is also filtered by the kidneys and
was therefore evaluated for differences between the HFD and
chow-fed groups. Ruggiero et al. [36] found no significant
changes in creatinine levels after C57BL mice consumed a
45% fat diet for sixteen weeks; the authors mentioned this
indicated early stages of renal damage without severe func-
tional damage (Table 2). In the present study, no statistically
significant differences were observed between the urinary
protein to creatinine ratio for animals ingesting the HFD as
compared to the chow-fed animals (Table 2), indicating that
the filtration abilities of the glomeruli were not damaged by
theHFD or at least not to the extent of allowing large proteins
to be excreted. With a longer duration feeding protocol,
research suggests that the HFD may result in sustained
elevations in blood glucose concentrations further leading to
increased stress on the kidneys.
Plasma cystatin C is considered a marker of early renal
dysfunction and the lack of difference between the cystatin C
concentrations of the HFD and chow-fed rats indicates that
the six-week feeding protocolmay not have been long enough
to initiate functional renal damage (Table 2). The HFD
group did develop higher concentrations of plasma cystatin
C; however, this difference was not statistically significant
(Table 2). Although cystatin C levels in plasma have been
shown to be an early sensitive marker of renal dysfunction,
these results indicate that the kidneys of the HFD-fed rats
were not damaged enough so as to prevent cystatin C from
being filtered [22–24, 43]. Muntner et al. [44] demonstrated
that serum cystatin C can be elevated in subjects who do
not exhibit signs of micro- or macroalbuminuria or kidney
disease. Rather, the authors concluded that serum cystatin
C was correlated with cardiovascular disease in overweight
subjects [44]. Therefore, plasma cystatin C alone may not be
an accurate estimation of GFR.
H
2
O
2
is an early marker of oxidative stress and inflam-
mation. Despite the increased renal perfusion pressure
that is associated with hypertension and elevated H
2
O
2
excretion, there was no significant difference in urinary
H
2
O
2
: creatinine ratio between the two groups (Table 2).
Elevated H
2
O
2
in the HFD group would have indicated early
renal damage, as H
2
O
2
has been found to be elevated prior
to GFR decline, proteinuria, and more robust inflammatory
and fibrotic responses following high fat feedings [30, 37, 38].
Overall, these results demonstrate that although prior studies
indicate that the HFD rats develop plasma and vascular
oxidative stress and inflammation in addition to endothelial
dysfunction [13, 14], these pathologies were not sufficient to
impair renal function.
Western blot analyses established no significant dif-
ference between the TNF𝛼 concentrations of renal tissue
isolated from HFD and chow-fed rats (Figure 2). Although
increased TNF𝛼 expression in adipose tissue has been shown
to promote to insulin resistance in overweight and obese
rodent models [45, 46], there was no indication that the
HFD increased renal tissue expression of this inflammatory
cytokine (Figure 2). There was also no increase in IL-6
expression (Figure 3), a proinflammatory cytokine. Other
experimental models of renal injury indicate that increases
in IL-6 secretion are not necessarily an integral step in
progressive renal failure [47]. Overall, the lack of significant
findings in markers of early renal dysfunction, such as
proteinuria and urinary H
2
O
2
, supports the lack of increases
in cytokine expression. Chronic increased IL-6 levels are an
indication of continued TNF𝛼 production and activation of
inflammatory pathways. Despite the controversy regarding
the differing effects of IL-6 as a cytokine and myokine, it
continues to be studied as a marker of inflammation in
HFD-induced obesity. Studies on both overweight and obese
women have found that serum TNF𝛼 and IL-6 levels were
positively correlated [48] while Ozay et al. [35] found that
HFD-induced obesity in male Wistar albino rats (22% fat for
12weeks) increased plasmaTNF𝛼without altering plasma IL-
6. Conversely, Kaya et al. [49] found that IL-6 levels in obese
human subjects were higher in both plasma and adipose
tissue compared to TNF𝛼. Stemmer et al. [10] examined the
effect of HFD (40% of calories from butter fat for 11 months)
onmaleWistar rats and the creation of an inflammatory renal
environment. Their results indicate an increase of IL-6 and
TNF𝛼 in retroperitoneal fat and in the kidneys, while there
was no increase in circulating IL-6.
Previous studies of the 6-week HFD rats showed that
plasma TBARS, a measure of whole body oxidative stress,
was increased in comparison to chow-fed controls [13].
Despite the increased plasma TBARS, renal TBARS were
not significantly different between chow and HFD-fed rats
(Table 2). These results indicate that although the HFD rats
exhibited systemic oxidative stress, oxidative stress within the
kidneys is not yet evident. Moreover, no significant difference
between oxidative DNA/RNA damage between the experi-
mental and control groups was observed (Table 2). Oxidative
stress, examined via TBARS and DNA/RNA oxidation, is
positively correlated [50]. The lack of significant TNF𝛼 and
IL-6 expression in renal tissue examined in the present study
is consistent with the observed lack of oxidative stress within
the kidneys as inflammation and oxidative stress are typically
correlated [51].
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In conclusion, aside from morphological changes, the only
major statistically significant findings in this study were an
increase in visceral adiposity and renal mass following a
short-term HFD. This study is novel in that it is the first
to examine a HFD for only six weeks; prior to this study,
the shortest feeding protocol that is evident in the literature
is four weeks at which point only morphological changes
were examined as opposed to measures of renal function.
Previous research conducted on the six-week HFD rat model
showed evidence of metabolic syndrome including signifi-
cant vascular oxidative stress and inflammation, endothelial
dysfunction, hypertension, hyperglycemia, hyperleptinemia,
and impaired glucose tolerance [13, 14].
It is possible that the methods used in this study might
not have been sensitive enough to detect subtle changes in
renal function. In prior studies by our laboratory, 6 weeks
of HFD significantly increased plasma concentrations of the
ketone beta-hydroxybutyrate from 4.72±0.31 in chow rats to
7.18 ± 0.77mg/dL in the HFD animals [14]. Considering that
ketogenic diets can reduce renal responses to glucose, it is also
possible that the HFD exerts a protective effect in the kidney
[51].This was shown in a prior study of mousemodels of type
2 diabetes with nephropathy in which 8 weeks of consuming
a ketogenic diet fully normalized albumin : creatinine ratios
and the expression of stress-related genes [51]. Therefore, it
is apparent from the current study that prolonged hyper-
glycemia and inflammation are likely necessary to induce
significant changes within the kidneys or that HFD may
exert some protective effects through increased generation of
ketones.
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